Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of KP-001 in Healthy Adult Males
jRCT2071230093Phase 1Completed
- Sponsor
- Kaken Pharmaceutical Co., Ltd.
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of KP001, sponsored by Kaken Pharmaceutical Co., Ltd. Primary endpoints: Pharmacokinetics of KP-001 and its metabolites and Safety and tolerability of KP-001. Started Nov 2023; status: completed.
02
Drugs
KP001
Beyond the preview
Go deeper on jRCT2071230093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230093.